← Leaderboards
Andrea Hagemann
Washington University
$1,761,789
Attributed
$1,761,789
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $635.9K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,761,789 · 1
By mechanism
P50$1,761,789 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Timothy J Eberlein$71,591,509
- John Morris$91,785,862
- Joel Gelernter$58,128,052
- Joseph Piven$85,332,682
- Lilianna Solnica-Krezel$20,466,821
Others in their field
Other Rising Stars on “Fda Approved”
- Suma Babu · Massachusetts General Hospital$26,348,733
- Sabrina Paganoni · Massachusetts General Hospital$26,348,733
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Michael George Natchus · Emory University$10,548,554
- John Alam · Eip Pharma, Inc.$10,411,018
- George Gaitanaris · Omeros Corporation$6,689,019
Research focus
Fda ApprovedAftercareAtypical Endometrial HyperplasiasAgonistAtypiaBehavior TherapyBiomarker IdentificationBiopsyBody Weight DecreasedBariatric SurgeryCombined Modality TherapyBehavioralDiagnosisEarly DiagnosisEfficacy EvaluationEndometrialEndometrial CarcinomaEndometrial HyperplasiaEnrollmentEnsureCancer PreventionEstrogen ReceptorsEstrogensFertility
Grant awards (3)
Project 3: Primary Prevention and Uterine Preservation in Premenopausal Women with Obesity and Endometrial Hyperplasia/Cancer$635,886
P50 · FY2025 · CA · contact PI
Project 3: Primary Prevention and Uterine Preservation in Premenopausal Women with Obesity and Endometrial Hyperplasia/Cancer$528,932
P50 · FY2024 · CA · contact PI
Project 3: Primary Prevention and Uterine Preservation in Premenopausal Women with Obesity and Endometrial Hyperplasia/Cancer$596,971
P50 · FY2023 · CA · contact PI